4STAHL SM. Essential psychopharmacology: neuroscientific basis and practical applications. 2nd ed[M]. Cambridge:Cambridge University Press,2000. 199-204.
5YAMADA M. Pharmacogenomics and antidepression research [J].Nihon Shinkei Seishin Yakurigaku Zasshi, 2003,23 (2) :67-73.
6BOSKER FJ, WESTERINK BH, CREMERS TI, et al. Future antidepressants: what is in the pipeline and what is missing? [J].CNS Drugs, 2004,18 ( 11 ): 705-732.
7NEMEROFF CB, OWENS MJ. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis [J].CNS Spectr, 2004,9(6 Suppl 4) :23-31.
8FINFGELD DL. Serotonin syndrome and the use of SSRIs[J]. JPsychosoc Nurs Ment Health Serv, 2004,42 (2): 16-20.
9MASAND PS, GUPTA S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion,and mirtazapine [ J ]. Ann Clin Psychiatry, 2002,14 ( 3 ): 175-182.
10KADHE NG, CHILLAR AJ, DESHMUKH YA. Reboxetine: a novel antidepressant [J]. J Postgard Med, 2003,49(4) :373-375.
